Subject
Cardiology and Cardiovascular Medicine
Reference17 articles.
1. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions;Levine;Circulation,2011
2. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes;Storey;J Am Coll Cardiol,2007
3. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin;Husted;Eur Heart J,2006
4. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009
5. Prevention of Cardiovascular events (eg Death from Heart or Vascular Disease, Heart attack, or Stroke) in patients with prior heart attack using ticagrelor compared to placebo on a background of aspirin (PEGASUS). Available at: http://clinicaltrials.gov/show/NCT01225562. Updated September 26, 2014. Accessed on November 23, 2014.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献